Core Insights - The company reported a revenue of RMB 1.442 billion for the six months ending June 30, 2025, representing a year-on-year decrease of 9.98% [1] - The company incurred a loss attributable to shareholders of RMB 20.231 million, compared to a profit of RMB 30.233 million in the same period last year, resulting in a basic loss per share of RMB 0.02 [1] - The decline in revenue was primarily due to an approximately 18.3% drop in the average selling price of hydrogenated phenolic chemicals, despite a 10.6% increase in sales volume [1] - The gross profit margin decreased from 4.5% in the first half of 2024 to 1.6% in the same period of 2025, mainly because the average procurement price of raw materials for hydrogenated phenolic chemicals fell at a slower rate than the average selling price [1]

Core Viewpoint - The company reported a decline in revenue and a shift from profit to loss in its interim results for the six months ending June 30, 2025, primarily influenced by changes in average product prices and procurement costs [1] Financial Performance - Revenue for the period was RMB 1.442 billion, representing a year-on-year decrease of 9.98% [1] - The loss attributable to the company's owners was RMB 20.231 million, compared to a profit of RMB 30.233 million in the same period last year [1] - Earnings per share showed a loss of RMB 0.02 [1] Operational Metrics - The company's operational performance remained stable, with capacity utilization rates for major products largely unchanged [1] - Product sales were reported to have achieved consistent full sales [1] Production Capacity - The production capacity for hydrogenated phenolic chemicals was approximately 400,000 tons per year [1] - The LNG production facility had a capacity of about 72,000 tons per year [1] - Hydrogen production capacity was approximately 317 million cubic meters per year, including the capacity from the joint venture Jinjiang Refining [1]

Core Viewpoint - The company reported a decline in revenue and a loss for the first half of 2025, primarily influenced by changes in average selling prices and procurement costs [1] Financial Performance - Revenue for the six months ending June 30, 2025, was RMB 1.442 billion, a decrease of 9.98% year-on-year [1] - The loss attributable to the company's owners was RMB 20.231 million, compared to a profit of RMB 30.233 million in the same period last year [1] - Earnings per share were reported at a loss of RMB 0.02 [1] Operational Metrics - The company's operational performance was stable, with capacity utilization rates for major products remaining consistent [1] - The production capacity for hydrogenated phenolic chemicals was approximately 400,000 tons per year, LNG production facilities had a capacity of about 72,000 tons per year, and hydrogen production capacity was around 317 million cubic meters per year, including the capacity from the joint venture Jinjiang Refining [1]

Group 1 - The core viewpoint of the article indicates that Jinyuan Hydrogenation (02502) expects a loss of approximately RMB 20.1 million for the six months ending June 30, 2025, compared to a revenue of approximately RMB 30.3 million in the same period of 2024 [1] - The downward adjustment in performance estimates is primarily due to the narrowing gross margin of the company's main product, hydrogenated phenolic chemicals [1] - The average price difference between the products and the raw material, crude benzene, decreased by approximately 11.5% in the first half of 2025 compared to the same period in 2024, as the price adjustments of the products and their raw materials did not align [1]

Group 1 - The company, Jinyuan Hydrogenation (02502.HK), expects a loss of approximately RMB 20.1 million for the six months ending June 30, 2025, compared to a revenue of about RMB 30.3 million in the same period of 2024 [1] - The downward revision of the performance estimate is primarily due to the narrowing gross margin of the company's main product, hydrogenated phenolic chemicals [1] - The average price difference between the products and the raw material, crude benzene, decreased by approximately 11.5% in the first half of 2025 compared to the same period in 2024 [1]

Core Viewpoint - The company, Jinyuan Hydrogenation (02502), anticipates a loss of approximately RMB 20.1 million for the six months ending June 30, 2025, compared to a revenue of about RMB 30.3 million for the same period in 2024 [1] Group 1 - The estimated performance downgrade is primarily due to the narrowing gross margin of the company's main product, hydrogenated phenolic chemicals [1] - The price difference between the products and their raw material, crude benzene, has decreased by approximately 11.5% in the first half of 2025 compared to the same period in 2024 [1]